
July 2 (Reuters) - Cytosorbents Corp CTSO.O:
CYTOSORBENTS PROVIDES U.S. FDA AND HEALTH CANADA REGULATORY UPDATE FOR DRUGSORB-ATR
CYTOSORBENTS CORP - FDA SCHEDULES APPEAL HEARING DATE FOR DRUGSORB-ATR
CYTOSORBENTS CORP - FDA REVIEW PROCESS EXPECTED TO COMPLETE BY END OF AUGUST 2025
CYTOSORBENTS CORP - HEALTH CANADA ISSUES NOTICE OF REFUSAL FOR DRUGSORB-ATR
CYTOSORBENTS CORP - TO FILE REQUEST FOR RECONSIDERATION WITH HEALTH CANADA